- Home
- SNGX vs BON Comparison
SNGX vs BON Comparison
Compare SNGX & BON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- BON
- Stock Information
- Founded
- SNGX 1987
- BON 2006
- Country
- SNGX United States
- BON China
- Employees
- SNGX N/A
- BON N/A
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- BON Medicinal Chemicals and Botanical Products
- Sector
- SNGX Health Care
- BON Health Care
- Exchange
- SNGX Nasdaq
- BON Nasdaq
- Market Cap
- SNGX 6.1M
- BON 4.3M
- IPO Year
- SNGX 1987
- BON 2021
- Fundamental
- Price
- SNGX $2.30
- BON $0.74
- Analyst Decision
- SNGX
- BON
- Analyst Count
- SNGX 0
- BON 0
- Target Price
- SNGX N/A
- BON N/A
- AVG Volume (30 Days)
- SNGX 30.0K
- BON 2.5M
- Earning Date
- SNGX 03-21-2025
- BON 03-21-2025
- Dividend Yield
- SNGX N/A
- BON N/A
- EPS Growth
- SNGX N/A
- BON N/A
- EPS
- SNGX N/A
- BON 0.17
- Revenue
- SNGX $364,183.00
- BON $23,844,556.00
- Revenue This Year
- SNGX N/A
- BON $223.38
- Revenue Next Year
- SNGX $119.78
- BON $18.82
- P/E Ratio
- SNGX N/A
- BON $4.69
- Revenue Growth
- SNGX N/A
- BON N/A
- 52 Week Low
- SNGX $1.83
- BON $0.74
- 52 Week High
- SNGX $14.88
- BON $5.31
- Technical
- Relative Strength Index (RSI)
- SNGX 45.88
- BON 32.07
- Support Level
- SNGX $2.21
- BON $0.82
- Resistance Level
- SNGX $2.32
- BON $1.21
- Average True Range (ATR)
- SNGX 0.12
- BON 0.28
- MACD
- SNGX 0.02
- BON -0.01
- Stochastic Oscillator
- SNGX 50.00
- BON 0.01
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About BON Bon Natural Life Limited
Bon Natural Life Ltd is engaged in the manufacturing of personal care ingredients, such as plants extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements. Xi'an App-Chem is devoted to providing high quality and competitive prices and a stable supply of products and services for the functional food, personal care, natural medicine and other industries. It provides these products and services for third party customers, as well as for its own proprietary brands. The company has its geographic presence in PRC and in Overseas. The company derives maximum revenue from Bioactive food ingredients.